Clincosm LogoSign in Get a demo

AML

Showing 51 - 75 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • AML
  • DC AML Vaccine
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 25, 2022

AML Trial in Hangzhou (MAX-40279-01)

Recruiting
  • AML
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University
Jan 18, 2022

Severe Infections on Acute Myeloid Leukemia (AML) Patients

Recruiting
  • AML
  • Adult
  • Observation
  • Civitanova Marche, Ancona, Italy
  • +45 more
Dec 31, 2021

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Acute Myelogenous Leukemia, AML, Advanced MDS Trial in Miami (Pevonedistat, Cytarabine)

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • Miami, Florida
    University of Miami
Dec 7, 2021

AML Trial in Netherlands (Flotetuzumab)

Withdrawn
  • AML
  • Amsterdam, Netherlands
  • +3 more
Dec 20, 2021

AML Trial (APVO436)

Withdrawn
  • AML
  • APVO436
  • (no location specified)
Nov 29, 2021

AML, Advanced MDS, ALL Trial in Chicago, New York (OTS167IV)

Terminated
  • AML
  • +4 more
  • Chicago, Illinois
  • +1 more
Nov 15, 2021

AML, Hyperleukocytosis Trial in Monterrey (Vinblastine, Hydroxyurea capsules)

Recruiting
  • AML
  • Hyperleukocytosis
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Oct 9, 2021

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

AML Trial in Monterrey (Venetoclax 100 MG, Itraconazole capsule, Azacitidine Injection)

Recruiting
  • AML
  • Venetoclax 100 MG
  • +2 more
  • Monterrey, Nuevo LEON, Mexico
    Andres Gomez
Sep 7, 2021

AML, ALL, MDS Trial in Germany (Peripheral blood stem cells)

Recruiting
  • AML
  • +2 more
  • Peripheral blood stem cells
  • Bonn, Germany
  • +8 more
Aug 25, 2021

AML, Acute Myelogenous Leukemia Trial (Scaling and Root Planing)

Not yet recruiting
  • AML
  • Acute Myelogenous Leukemia
  • Scaling and Root Planing
  • (no location specified)
Aug 3, 2021

AML, MDS Trial in Belgium, United States (NKR-2)

Completed
  • AML
  • MDS
  • NKR-2
  • Aurora, Colorado
  • +6 more
Apr 30, 2021

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

Acute Myeloid Leukemia, Adult, AML, AML, Adult Trial in La Jolla (Fludarabine, Vyxeos)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
Mar 30, 2021

AML Trial in Valencia (Registry)

Recruiting
  • AML
  • Registry
  • Valencia, Spain
    Hospital La Fe
Mar 22, 2021

AML Trial in Yanda (CAR-?dT)

Recruiting
  • AML
  • CAR-γδT
  • Yanda, Hebei, China
    Hebei yanda Ludaopei Hospital
Mar 11, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
Has Results
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

AML Trial in Peking (CAR-T cells)

Not yet recruiting
  • AML
  • CAR-T cells
  • Peking, China
    Peking University People's Hospital (PKUPH)
Feb 19, 2021

AML Trial in Boston (Etoposide, Cytarabine, Lenalidomide)

Active, not recruiting
Has Results
  • AML
  • Boston, Massachusetts
  • +2 more
Jan 13, 2021

Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

Terminated
Has Results
  • Leukemia, Myeloid, Chronic
  • +8 more
  • Stem Cell Transplant
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 31, 2020

AML, FLT3-ITD Mutation Trial in Hong Kong (Quizartinib, Omacetaxine Mepesuccinate Injection)

Unknown status
  • AML
  • FLT3-ITD Mutation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 9, 2020

AML, Recurrent, Refractory Trial in Jinan (Allogeneic NK cell regimen group)

Not yet recruiting
  • AML
  • +3 more
  • Allogeneic NK cell regimen group
  • Jinan, Shandong, China
    The 2nd Hospital of Shandong University
Oct 21, 2020